No. NewAmsterdam Pharma (NAMS) does not pass the AAOIFI Shari’ah Standard 21 screen.
Yes. NewAmsterdam Pharma (NAMS) passes the Catholic screen based on the USCCB investment guidelines.
Yes. NewAmsterdam Pharma (NAMS) passes the Biblically Responsible Investing (BRI) screen.